Literature DB >> 9792806

Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42.

M Nanahoshi1, T Nishiuma, Y Tsujishita, K Hara, S Inui, N Sakaguchi, K Yonezawa.   

Abstract

Recent studies have revealed that the alpha4 protein, a mammalian homolog of yeast Tap42, is associated with the protein phosphatase 2A catalytic subunit (PP2A-C), however, effects of the association of alpha4 with PP2A-C on its phosphatase activity have not been examined, especially using physiologically relevant substrates in the signaling pathway of mTOR (the mammalian target of rapamycin) protein. Here, we report how this association affects the enzymatic activity of PP2A-C using the recombinant eIF-4E binding protein (4E-BP1) phosphorylated by immunoprecipitated mTOR as a substrate. PP2A-C dephosphorylated 4E-BP1 in vitro. The association of alpha4 and Tap42 with PP2A-C inhibited the phosphatase activity toward 4E-BP1. Rapamycin treatment, however, neither induced restoration of the phosphatase activity of PP2A-C nor caused dissociation of alpha4 and Tap42 from PP2A-C. Our study is the first report to reveal a potential regulatory role of alpha4 and Tap42 to inibit the phosphatase activity of PP2A-C toward the physiologically relevant substrate in the mTOR signaling. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792806     DOI: 10.1006/bbrc.1998.9493

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Specific interactions of PP2A and PP2A-like phosphatases with the yeast PTPA homologues, Ypa1 and Ypa2.

Authors:  Christine Van Hoof; Ellen Martens; Sari Longin; Jan Jordens; Ilse Stevens; Veerle Janssens; Jozef Goris
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

Review 2.  Signaling by target of rapamycin proteins in cell growth control.

Authors:  Ken Inoki; Hongjiao Ouyang; Yong Li; Kun-Liang Guan
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

3.  Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.

Authors:  Eva Kickstein; Sybille Krauss; Paul Thornhill; Désirée Rutschow; Raphael Zeller; John Sharkey; Ritchie Williamson; Melanie Fuchs; Andrea Köhler; Hartmut Glossmann; Rainer Schneider; Calum Sutherland; Susann Schweiger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 4.  Serine-threonine protein phosphatases: Lost in translation.

Authors:  Victoria Kolupaeva
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-08-20       Impact factor: 4.739

5.  Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism.

Authors:  Siwang Yu; Guoxiang Shen; Tin Oo Khor; Jung-Hwan Kim; Ah-Ng Tony Kong
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

6.  Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis.

Authors:  Alexandre Huber; Bernd Bodenmiller; Aino Uotila; Michael Stahl; Stefanie Wanka; Bertran Gerrits; Ruedi Aebersold; Robbie Loewith
Journal:  Genes Dev       Date:  2009-08-15       Impact factor: 11.361

7.  Functional analysis of the PP2A subfamily of protein phosphatases in regulating Drosophila S6 kinase.

Authors:  Vincent A Bielinski; Marc C Mumby
Journal:  Exp Cell Res       Date:  2007-05-16       Impact factor: 3.905

Review 8.  TOR-dependent control of autophagy: biting the hand that feeds.

Authors:  Thomas P Neufeld
Journal:  Curr Opin Cell Biol       Date:  2009-12-16       Impact factor: 8.382

9.  Interaction with Tap42 is required for the essential function of Sit4 and type 2A phosphatases.

Authors:  Huamin Wang; Xiaodong Wang; Yu Jiang
Journal:  Mol Biol Cell       Date:  2003-07-25       Impact factor: 4.138

10.  Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway.

Authors:  Lei Liu; Long Chen; Yan Luo; Wenxing Chen; Hongyu Zhou; Baoshan Xu; Xiuzhen Han; Tao Shen; Shile Huang
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.